Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+14.29%)
As of: Nov 16, 2026 · 1:33 PM EST

Elite Pharmaceuticals (ELTP) Total Non-Current Liabilities (2009 - 2026)

Updated

Elite Pharmaceuticals' Total Non-Current Liabilities came in at $3.97 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 91.2% from $44.99 million a year earlier and down 9.8% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Total Non-Current Liabilities was $22.02 million, down 29.1% from FY2025.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of 39.1% (FY2021 to FY2026).
  • Going back by fiscal year, Total Non-Current Liabilities was $31.03 million in FY2025 (+138.3%), $13.02 million in FY2024 (+217.4%), $4.1 million in FY2023 (+26.9%) and $3.23 million in FY2022 (-23.5%).
  • The fiscal Q2 2027 figure represents the lowest quarterly Total Non-Current Liabilities since fiscal Q4 2022.
  • Year-over-year, Total Non-Current Liabilities has declined for four consecutive quarters, with growth averaging 67.9% over the last eight quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in fiscal Q3 2023 (growth of 384.5%), and the weakest in fiscal Q1 2027 (a decline of 91.7%).
  • Business Quant data shows ELTP's Total Non-Current Liabilities at $4.4 million (Q1 2027), $22.02 million (Q4 2026) and $32.91 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,287.23 Bn 1,260.84 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 685.24 Bn 605.10 Bn 17.30 Bn 102.65 Bn
3 AbbVie 523.42 Bn 491.43 Bn 13.12 Bn 117.60 Bn
4 Merck 361.12 Bn 324.06 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 312.86 Bn 286.10 Bn - -
6 Astrazeneca 286.52 Bn 260.04 Bn 13.26 Bn -36.84 Bn
7 Amgen 252.28 Bn 203.93 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 209.33 Bn 184.44 Bn 6.73 Bn 36.05 Bn
9 Pfizer 165.02 Bn 112.37 Bn 12.56 Bn 96.04 Bn
10 Elite Pharmaceuticals 393.15 Mn 266.57 Mn 15.99 Mn 3.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.97 Mn
Jun 30, 2026 4.40 Mn
Mar 31, 2026 22.02 Mn
Dec 31, 2025 32.91 Mn
Sep 30, 2025 44.99 Mn
Jun 30, 2025 52.89 Mn
Mar 31, 2025 31.03 Mn
Dec 31, 2024 39.62 Mn
Sep 30, 2024 28.08 Mn
Jun 30, 2024 15.58 Mn
Mar 31, 2024 13.02 Mn
Dec 31, 2023 9.12 Mn
Sep 30, 2023 6.55 Mn
Jun 30, 2023 4.30 Mn
Mar 31, 2023 4.10 Mn
Dec 31, 2022 15.89 Mn
Sep 30, 2022 16.31 Mn
Jun 30, 2022 15.50 Mn
Mar 31, 2022 3.23 Mn
Dec 31, 2021 3.28 Mn
API Access

Elite Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ELTP&period=max&api_key=YOUR_API_KEY